Your Support Fuels Revolutionary Breakthroughs
Dr. Avtar Roopra, a four-time CURE Epilepsy grantee, and his research assistant, Dr. Olivia Hoffman, are working on what could be the first disease-modifying treatment for epilepsy. They found that an already FDA-approved arthritis medication not only stops seizures in rats, but also reverses the cognitive impact of epilepsy.
Labs like Dr. Roopra's are being forced to scale back their work, because federal research funding remains uncertain. With an unclear future, promising scientists like Dr. Hoffman are being driven out of the field.
Your gift today can help. Your support helps keep groundbreaking research like theirs moving forward — and keeps future leaders in the fight to find a cure.
Research discoveries like Dr. Roopra's take decades of investment.
Over the past decade, four successive CURE Epilepsy grants have propelled Dr. Roopra's research at pivotal moments. We supported the development of preliminary data that helped the lab secure its first major federal award, an NIH R01 grant.
However, just as we are accelerating towards the key next step of human clinical trials, federal funding uncertainty has put the brakes on this progress. Survival, not innovation, has become the norm. This is why CURE Epilepsy year-end donor support is more critical than ever.
Thank you for keeping promising work like Dr. Roopra's moving forward.